Sirtuin deacylases: a molecular link between metabolism and immunity

Lysine deacetylation by the NAD+‐dependent family of sirtuins has been recognized as an important post‐translational modification regulating a wide range of cellular processes. These lysine deacetylases have attracted much interest based on their ability to promote survival in response to stress. Sirtuins require NAD+ for their enzymatic activity, suggesting that these enzymes may represent molecular links between cell metabolism and several human disorders, including diabetes and cancer. Inflammation represents a pathological situation with clear connections to metabolism and aging in humans, raising the possibility that sirtuins may also play an important role during a normal and/or a pathological immune response. A growing body of data has confirmed the immunomodulatory properties of sirtuins, although often with contrasting and opposing conclusions. These observations will be summarized herein and the possible strategies that may lead to the development of novel therapeutic approaches to treat inflammation briefly discussed.

[1]  A. Akhmedov,et al.  Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction. , 2013, Antioxidants & redox signaling.

[2]  G. Feldmann,et al.  The NAD+-dependent Histone Deacetylase SIRT6 Promotes Cytokine Production and Migration in Pancreatic Cancer Cells by Regulating Ca2+ Responses* , 2012, The Journal of Biological Chemistry.

[3]  C. Deng,et al.  Progression of Chronic Liver Inflammation and Fibrosis Driven by Activation of c-JUN Signaling in Sirt6 Mutant Mice* , 2012, The Journal of Biological Chemistry.

[4]  D. Green,et al.  Metabolic checkpoints in activated T cells , 2012, Nature Immunology.

[5]  L. Mcphail,et al.  Fueling the flame: bioenergy couples metabolism and inflammation , 2012, Journal of leukocyte biology.

[6]  A. Mobasheri,et al.  Resveratrol Modulates Interleukin-1β-induced Phosphatidylinositol 3-Kinase and Nuclear Factor κB Signaling Pathways in Human Tenocytes , 2012, The Journal of Biological Chemistry.

[7]  S. Ismail,et al.  Serum levels of visfatin and omentin‐1 in patients with psoriasis and their relation to disease severity , 2012, The British journal of dermatology.

[8]  L. Guarente,et al.  High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction. , 2012, Cell metabolism.

[9]  S. Cho,et al.  Chitooligosaccharide Induces Mitochondrial Biogenesis and Increases Exercise Endurance through the Activation of Sirt1 and AMPK in Rats , 2012, PloS one.

[10]  Alexander S. Banks,et al.  Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. , 2012, Physiological reviews.

[11]  O. Leo,et al.  Complex roles of members of the ADP-ribosyl transferase super family in immune defences: looking beyond PARP1. , 2012, Biochemical pharmacology.

[12]  C. McCall,et al.  NAD+-dependent Sirtuin 1 and 6 Proteins Coordinate a Switch from Glucose to Fatty Acid Oxidation during the Acute Inflammatory Response* , 2012, The Journal of Biological Chemistry.

[13]  J. Auwerx,et al.  The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. , 2012, Cell metabolism.

[14]  H. Cohen,et al.  The Tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetes , 2012, Aging.

[15]  Hongwei Yao,et al.  SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. , 2012, The Journal of clinical investigation.

[16]  M. Ohh,et al.  The updated biology of hypoxia‐inducible factor , 2012, The EMBO journal.

[17]  R. Johnson,et al.  Influence of hypoxia‐inducible factor 1α on dendritic cell differentiation and migration , 2012, European Journal of Immunology.

[18]  A. Neyrinck,et al.  Sirtuin inhibition attenuates the production of inflammatory cytokines in lipopolysaccharide-stimulated macrophages. , 2012, Biochemical and biophysical research communications.

[19]  S. Meroueh,et al.  A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53 , 2012, EMBO molecular medicine.

[20]  E-C Kim,et al.  Mechanical stress‐activated immune response genes via Sirtuin 1 expression in human periodontal ligament cells , 2012, Clinical and experimental immunology.

[21]  E. Mazzon,et al.  The NAMPT inhibitor FK866 reverts the damage in spinal cord injury , 2012, Journal of Neuroinflammation.

[22]  Johan Auwerx,et al.  Sirtuins as regulators of metabolism and healthspan , 2012, Nature Reviews Molecular Cell Biology.

[23]  J. Wan,et al.  Therapeutic benefits of the group B3 vitamin nicotinamide in mice with lethal endotoxemia and polymicrobial sepsis. , 2012, Pharmacological research.

[24]  P. Davies,et al.  Resveratrol mitigates lipopolysaccharide‐ and Aβ‐mediated microglial inflammation by inhibiting the TLR4/NF‐κB/STAT signaling cascade , 2012, Journal of neurochemistry.

[25]  D. Green,et al.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.

[26]  Johan Auwerx,et al.  Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase , 2011, Science.

[27]  F. Andris,et al.  Sirtuin 1 Promotes Th2 Responses and Airway Allergy by Repressing Peroxisome Proliferator-Activated Receptor-γ Activity in Dendritic Cells , 2011, The Journal of Immunology.

[28]  M. V. Vander Heiden,et al.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.

[29]  S. Imai,et al.  Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. , 2011, Cell metabolism.

[30]  Yi Shi,et al.  Inhibition of pre-B cell colony-enhancing factor attenuates inflammation and apoptosis induced by pandemic H1N1 2009 in lung endothelium , 2011, Respiratory Physiology & Neurobiology.

[31]  E. Cesarini,et al.  Sirtinol Treatment Reduces Inflammation in Human Dermal Microvascular Endothelial Cells , 2011, PloS one.

[32]  Zhike Lu,et al.  The First Identification of Lysine Malonylation Substrates and Its Regulatory Enzyme* , 2011, Molecular & Cellular Proteomics.

[33]  F. Tay,et al.  Chronic resveratrol intake reverses pro-inflammatory cytokine profile and oxidative DNA damage in ageing hybrid mice , 2011, AGE.

[34]  Matt Kaeberlein,et al.  Absence of effects of Sir2 over-expression on lifespan in C. elegans and Drosophila , 2011, Nature.

[35]  Michael Detmar,et al.  SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance , 2011, Annals of the rheumatic diseases.

[36]  D. Green,et al.  HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.

[37]  A. Nikiforov,et al.  Pathways and Subcellular Compartmentation of NAD Biosynthesis in Human Cells , 2011, The Journal of Biological Chemistry.

[38]  J. Auwerx,et al.  PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. , 2011, Cell metabolism.

[39]  K. Tracey,et al.  HMGB1 is a therapeutic target for sterile inflammation and infection. , 2011, Annual review of immunology.

[40]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[41]  P. Pandolfi,et al.  SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. , 2011, Cancer cell.

[42]  L. Guarente,et al.  SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production , 2011, Oncogene.

[43]  C. McCall,et al.  NAD+-dependent SIRT1 Deacetylase Participates in Epigenetic Reprogramming during Endotoxin Tolerance* , 2011, The Journal of Biological Chemistry.

[44]  B. Lüscher,et al.  SIRT2 regulates NF-κB-dependent gene expression through deacetylation of p65 Lys310 , 2010, Journal of Cell Science.

[45]  P. Distefano,et al.  SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183. , 2010, Future medicinal chemistry.

[46]  P. Elliott,et al.  Oral Resveratrol Reduces Neuronal Damage in a Model of Multiple Sclerosis , 2010, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[47]  Xiaoling Xu,et al.  Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. , 2010, Cell metabolism.

[48]  I. Rahman,et al.  Cigarette smoke-induced autophagy is regulated by SIRT1-PARP-1-dependent mechanism: implication in pathogenesis of COPD. , 2010, Archives of biochemistry and biophysics.

[49]  Qing Xu,et al.  Myeloid Deletion of SIRT1 Induces Inflammatory Signaling in Response to Environmental Stress , 2010, Molecular and Cellular Biology.

[50]  Junjie Chen,et al.  Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. , 2010, Molecular cell.

[51]  Erika L. Pearce Metabolism in T cell activation and differentiation. , 2010, Current opinion in immunology.

[52]  J. Olefsky,et al.  SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. , 2010, American journal of physiology. Endocrinology and metabolism.

[53]  I. Rahman,et al.  PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity. , 2010, Biochemical and biophysical research communications.

[54]  S. Honda,et al.  Fasting promotes the expression of SIRT1, an NAD+-dependent protein deacetylase, via activation of PPARα in mice , 2010, Molecular and Cellular Biochemistry.

[55]  E. Kalkhoven,et al.  Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. , 2010, Blood.

[56]  G. Gores,et al.  Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice. , 2010, The Journal of clinical investigation.

[57]  Orian S. Shirihai,et al.  The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α , 2010, Cell.

[58]  C. Cobelli,et al.  Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical Mechanisms , 2010, Diabetes.

[59]  R. Garofalo,et al.  SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1♦ , 2010, The Journal of Biological Chemistry.

[60]  De-Pei Liu,et al.  SIRT1 Suppresses Activator Protein-1 Transcriptional Activity and Cyclooxygenase-2 Expression in Macrophages* , 2009, The Journal of Biological Chemistry.

[61]  A. Ballestrero,et al.  Catastrophic NAD+ Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE , 2009, PloS one.

[62]  K. Tsuneyama,et al.  Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. , 2009, American journal of physiology. Endocrinology and metabolism.

[63]  Brian C. Smith,et al.  A continuous microplate assay for sirtuins and nicotinamide-producing enzymes. , 2009, Analytical biochemistry.

[64]  M. McBurney,et al.  The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice. , 2009, The Journal of clinical investigation.

[65]  S. Biswas,et al.  Endotoxin tolerance: new mechanisms, molecules and clinical significance. , 2009, Trends in immunology.

[66]  L. Altucci,et al.  Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors. , 2009, Journal of medicinal chemistry.

[67]  P. Elliott,et al.  A protein deacetylase SIRT1 is a negative regulator of metalloproteinase‐9 , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[68]  Karine Gilbert,et al.  The Small Molecule GMX1778 Is a Potent Inhibitor of NAD+ Biosynthesis: Strategy for Enhanced Therapy in Nicotinic Acid Phosphoribosyltransferase 1-Deficient Tumors , 2009, Molecular and Cellular Biology.

[69]  Bo Yang,et al.  The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability , 2009, Cell cycle.

[70]  C. Deng,et al.  Recent progress in the biology and physiology of sirtuins , 2009, Nature.

[71]  A. Harris,et al.  Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. , 2009, Blood.

[72]  K. Tsubota,et al.  Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation. , 2009, Investigative Ophthalmology and Visual Science.

[73]  R. Chen,et al.  Regulation of Hypoxia-Inducible Factor 2α Signaling by the Stress-Responsive Deacetylase Sirtuin 1 , 2009, Science.

[74]  P. Puigserver,et al.  GCN5-mediated Transcriptional Control of the Metabolic Coactivator PGC-1β through Lysine Acetylation* , 2009, The Journal of Biological Chemistry.

[75]  K. Birukov,et al.  SIRT1 Promotes Cell Survival under Stress by Deacetylation-Dependent Deactivation of Poly(ADP-Ribose) Polymerase 1 , 2009, Molecular and Cellular Biology.

[76]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[77]  J. Tyler,et al.  CBP/p300-mediated acetylation of histone H3 on lysine 56 , 2009, Nature.

[78]  Zheng Shen,et al.  Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[79]  Takashi Nakagawa,et al.  SIRT5 Deacetylates Carbamoyl Phosphate Synthetase 1 and Regulates the Urea Cycle , 2009, Cell.

[80]  Amy V. Lynch,et al.  Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators. , 2009, Bioorganic & medicinal chemistry letters.

[81]  Qing Xu,et al.  Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. , 2009, Cell metabolism.

[82]  Kirk C. Hansen,et al.  CBP / p300-mediated acetylation of histone H3 on lysine 56 , 2009, Nature.

[83]  B. K. Thakur,et al.  NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD+-sirtuin-1-dependent pathway. , 2009 .

[84]  Amy V. Lynch,et al.  Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators. , 2009, Journal of medicinal chemistry.

[85]  Véronique Kruys,et al.  Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner , 2009, Nature Medicine.

[86]  A. Schambach,et al.  NAMPT is essential for the G-CSF–induced myeloid differentiation via a NAD+–sirtuin-1–dependent pathway , 2009, Nature Medicine.

[87]  Howard Y. Chang,et al.  SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span , 2009, Cell.

[88]  J. D. de Sanctis,et al.  Serum adipokine levels in patients with systemic lupus erythematosus , 2009, Autoimmunity.

[89]  J. Olefsky,et al.  SIRT1 Exerts Anti-Inflammatory Effects and Improves Insulin Sensitivity in Adipocytes , 2008, Molecular and Cellular Biology.

[90]  N. Maulik,et al.  Akt/FOXO3a/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevity. , 2008, Journal of agricultural and food chemistry.

[91]  W. Staines,et al.  sirt1-null mice develop an autoimmune-like condition. , 2008, Experimental cell research.

[92]  Shiwei Song,et al.  A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis , 2008, Proceedings of the National Academy of Sciences.

[93]  P. Pfluger,et al.  Sirt1 protects against high-fat diet-induced metabolic damage , 2008, Proceedings of the National Academy of Sciences.

[94]  O. Leo,et al.  Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD , 2008, PloS one.

[95]  E. Hoffman,et al.  Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. , 2008, Developmental cell.

[96]  F. Berenbaum,et al.  Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. , 2008, Arthritis and rheumatism.

[97]  Chia-Fang Liu,et al.  The effect of water-soluble chitosan on macrophage activation and the attenuation of mite allergen-induced airway inflammation. , 2008, Biomaterials.

[98]  I. Rahman,et al.  SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[99]  Howard Y. Chang,et al.  SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin , 2008, Nature.

[100]  W. Greene,et al.  Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation. , 2008, Cell host & microbe.

[101]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[102]  M. Nagarkatti,et al.  Resveratrol (trans-3,5,4′-Trihydroxystilbene) Ameliorates Experimental Allergic Encephalomyelitis, Primarily via Induction of Apoptosis in T Cells Involving Activation of Aryl Hydrocarbon Receptor and Estrogen Receptor , 2007, Molecular Pharmacology.

[103]  Amy V. Lynch,et al.  Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes , 2007, Nature.

[104]  J. Milbrandt,et al.  Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. , 2007, Cell metabolism.

[105]  R. Nazar,et al.  Borrowing from Biology , 2007, Science.

[106]  B. Spiegelman,et al.  Skeletal Muscle Fiber-type Switching, Exercise Intolerance, and Myopathy in PGC-1α Muscle-specific Knock-out Animals* , 2007, Journal of Biological Chemistry.

[107]  Dudley Lamming,et al.  Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival , 2007, Cell.

[108]  S. Imai,et al.  The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals , 2007, Current opinion in gastroenterology.

[109]  I. Rahman,et al.  Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[110]  R. Swanson,et al.  Use of a Poly(ADP-Ribose) Polymerase Inhibitor to Suppress Inflammation and Neuronal Death After Cerebral Ischemia-Reperfusion , 2007, Stroke.

[111]  L. Guarente,et al.  SIRT1 Inhibits Transforming Growth Factor β-Induced Apoptosis in Glomerular Mesangial Cells via Smad7 Deacetylation* , 2007, Journal of Biological Chemistry.

[112]  P. Puigserver,et al.  Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.

[113]  T. White,et al.  Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38. , 2006, Biochemical and biophysical research communications.

[114]  F. Alt,et al.  SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β Cells , 2006, Cell.

[115]  Eric Verdin,et al.  Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2 , 2006, Proceedings of the National Academy of Sciences.

[116]  H. Cui,et al.  Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1β (IL-1β) in astrocyte cultures , 2006, Journal of Neuroimmunology.

[117]  R. DePinho,et al.  Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. , 2006, Cancer research.

[118]  M. Sánchez-Hidalgo,et al.  The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model , 2006, British journal of pharmacology.

[119]  Pingfang Liu,et al.  Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6 , 2006, Cell.

[120]  J. Gómez-Reino,et al.  Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis , 2006, Annals of the rheumatic diseases.

[121]  S. Imai,et al.  Poly(ADP-ribose) Polymerase-1-dependent Cardiac Myocyte Cell Death during Heart Failure Is Mediated by NAD+ Depletion and Reduced Sir2α Deacetylase Activity* , 2005, Journal of Biological Chemistry.

[122]  D. Fuchs,et al.  Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro. , 2005, Immunology letters.

[123]  M. Matsuda,et al.  Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.

[124]  Y. Turkoz,et al.  Effect of resveratrol in experimental osteoarthritis in rabbits , 2005, Inflammation Research.

[125]  Wilhelm Haas,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1 , 2005, Nature.

[126]  T. Standiford,et al.  Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. , 2005, American journal of respiratory and critical care medicine.

[127]  Q. Ma,et al.  Effect of resveratrol on activation of nuclear factor kappa-B and inflammatory factors in rat model of acute pancreatitis. , 2005, World journal of gastroenterology.

[128]  S. Imai,et al.  The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells* , 2004, Journal of Biological Chemistry.

[129]  Brian C. Smith,et al.  Coenzyme Specificity of Sir2 Protein Deacetylases , 2004, Journal of Biological Chemistry.

[130]  M. Mayo,et al.  Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase , 2004, The EMBO journal.

[131]  J. Marshall,et al.  Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. , 2004, The Journal of clinical investigation.

[132]  Steven P. Gygi,et al.  Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase , 2004, Science.

[133]  A. Sollevi,et al.  Nicotinamide does not influence cytokines or exhaled NO in human experimental endotoxaemia , 2004, Clinical and experimental immunology.

[134]  F. Andris,et al.  Reconstructing eukaryotic NAD metabolism. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[135]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[136]  R. Korthuis,et al.  Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. , 2003, Free radical biology & medicine.

[137]  J. Denu,et al.  The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. , 2003, Molecular cell.

[138]  M. Blombäck,et al.  Nicotinamide is a potent inhibitor of proinflammatory cytokines , 2003, Clinical and experimental immunology.

[139]  D. Sinclair,et al.  Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1* , 2002, The Journal of Biological Chemistry.

[140]  D. Gigot,et al.  Pre‐B‐cell colony‐enhancing factor, whose expression is up‐regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis , 2002, European journal of immunology.

[141]  E. Verdin,et al.  The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide–dependent deacetylase , 2002, The Journal of cell biology.

[142]  A. Yakovlev,et al.  Roles of DNA fragmentation factor and poly(ADP-ribose) polymerase in an amplification phase of tumor necrosis factor-induced apoptosis. , 2001, The Journal of biological chemistry.

[143]  H. Inui,et al.  Inflammatory responses to lipopolysaccharide are suppressed in 40% energy-restricted mice. , 2001, Journal of NutriLife.

[144]  R. Frye,et al.  Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. , 2000, Biochemical and biophysical research communications.

[145]  Rick B. Vega,et al.  The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes , 2000, Molecular and Cellular Biology.

[146]  L. Guarente,et al.  Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase , 2000, Nature.

[147]  J. Satoh,et al.  Inhibitory effect of nicotinamide on in vitro and in vivo production of tumor necrosis factor-alpha. , 1997, Immunology Letters.

[148]  I McNiece,et al.  Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor , 1994, Molecular and cellular biology.

[149]  G. Murcia,et al.  Identification of potential active-site residues in the human poly(ADP-ribose) polymerase. , 1993, The Journal of biological chemistry.

[150]  P. Langcake,et al.  The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury , 1976 .

[151]  C. Elvehjem,et al.  FACTORS AFFECTING THE GROWTH OF RATS RECEIVING NIACIN-TRYPTOPHAN-DEFICIENT DIETS , 1947 .

[152]  P. Elliott,et al.  Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man. , 2013, British journal of clinical pharmacology.

[153]  Yu-guang Du,et al.  Chitosan oligosaccharides protect mice from LPS challenge by attenuation of inflammation and oxidative stress. , 2011, International immunopharmacology.

[154]  Robert V Farese,et al.  SIRT 3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation , 2010 .

[155]  B. Lüscher,et al.  SIRT 2 regulates NFk B-dependent gene expression through deacetylation of p 65 Lys 310 , 2010 .

[156]  M. Perretti,et al.  Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase , 2001, Inflammation Research.

[157]  L. Peshkin,et al.  Supplemental Data Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span , 2008 .